Periodontal regeneration with enamel matrix derivative in reconstructive periodontal therapy: A systematic review

Journal of Periodontology

Volumn 83, Issue 6, 2012, Pages 707-720

  Koop, Richard ^a   Merheb, Joe ^a   Quirynen, Marc ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Enamel matrix proteins; Furcation defects; Gingival recession; Guided tissue regeneration, periodontal

Indexed keywords

ENAMEL MATRIX PROTEINS; ENAMEL PROTEIN;

ALVEOLAR BONE LOSS; GINGIVA DISEASE; HUMAN; METHODOLOGY; PERIODONTAL DISEASE; PERIODONTICS; PLASTIC SURGERY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

ALVEOLAR BONE LOSS; DENTAL ENAMEL PROTEINS; FURCATION DEFECTS; GINGIVAL RECESSION; GUIDED TISSUE REGENERATION, PERIODONTAL; HUMANS; PERIODONTAL DISEASES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECONSTRUCTIVE SURGICAL PROCEDURES;

EID: 84861820208     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2011.110266     Document Type: Review

References (88)

1. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet 2005;366:1809-1820.
2. Albandar JM, Brunelle JA, Kingman A. Destructive periodontal disease in adults 30 years of age and older in the United States, 1988-1994. J Periodontol 1999; 70:13-29.
3. Badersten A, Nilveus R, Egelberg J. Effect of non-surgical periodontal therapy. II. Severely advanced periodontitis. J C/in Periodontol 1984;11:63-76.
4. Claffey N, Egelberg J. Clinical indicators of probing attachment loss following initial periodontal treatment in advanced periodontitis patients. J Clin Periodontol 1995;22:690-696.
5. Stern IB, Everett FG, Robicsek K. S. Robicsek - A pioneer in the surgical treatment of periodontal disease. J Periodontol 1965;36:265-268.
6. Friedman N. Mucogingival surgery: The apically repositioned flap. J Periodontol 1962;33:328-340.
7. American Academy of Periodontology. Glossary of Periodontal Terms, 4th ed. Chicago: American Academy of Periodontology; 2001.
8. Nabers CL, Reed OM, Hamner JE 3rd. Gross and histologic evaluation of an autogenous bone graft 57 months postoperatively. J Periodontol 1972;43:702-704.
9. Bowers GM, Chadroff B, Carnevale R, et al. Histologic evaluation of new attachment apparatus formation in humans. Part II. J Periodontol 1989;60:675-682.
10. Bowers GM, Chadroff B, Carnevale R, et al. Histologic evaluation of new attachment apparatus formation in humans. Part III. J Periodontol 1989;60:683-693.
11. Nyman S, Lindhe J, Karring T, Rylander H. New attachment following surgical treatment of human periodontal disease. J Clin Periodontol 1982;9:290-296.
12. Lynch SE, Williams RC, Polson AM, et al. A combination of platelet-derived and insulin-like growth factors enhances periodontal regeneration. J Clin Periodontol 1989;16:545-548.
13. Lynch SE, de Castilla GR, Williams RC, et al. The effects of short-term application of a combination of platelet-derived and insulin-like growth factors on periodontal wound healing. J Periodontol 1991;62: 458-467.
14. Howell TH, Fiorellini JP, Paquette DW, Offenbacher S, Giannobile WV, Lynch SE. A phase I/II clinical trial to evaluate a combination of recombinant human platelet-derived growth factor-BB and recombinant human insulin-like growth factor-I in patients with periodontal disease. J Periodontol 1997;68:1186-1193.
15. Sculean A, Donos N, Windisch P, et al. Healing of human intrabony defects following treatment with enamel matrix proteins or guided tissue regeneration. J Periodontal Res 1999;34:310-322.
16. Cochran DL, Jones A, Heijl L, Mellonig JT, Schoolfield J, King GN. Periodontal regeneration with a combination of enamel matrix proteins and autogenous bone grafting. J Periodontol 2003;74:1269-1281.
17. Guida L, Annunziata M, Belardo S, Farina R, Scabbia A, Trombelli L. Effect of autogenous cortical bone particulate in conjunction with enamel matrix derivative in the treatment of periodontal intraosseous defects. J Periodontol 2007;78:231-238.
18. Trombelli L. Which reconstructive procedures are effective for treating the periodontal intraosseous defect? Periodontol 2000 2005;37:88-105.
19. Needleman IG, Worthington HV, Giedrys-Leeper E, Tucker RJ. Guided tissue regeneration for periodontal infra-bony defects. Cochrane Database Syst Rev 2006;2: CD001724.
20. Hammarström L. Enamel matrix, cementum development and regeneration. J Clin Periodontol 1997;24: 658-668.
21. Mellonig JT. Enamel matrix derivative for periodontal reconstructive surgery: Technique and clinical and histologic case report. Int J Periodontics Restorative Dent 1999;19:8-19.
22. Esposito M, Grusovin MG, Papanikolaou N, Coulthard P, Worthington HV. Enamel matrix derivative (Emdogain(R)) for periodontal tissue regeneration in intrabony defects. Cochrane Database Syst Rev 2009; (4): CD003875.
23. Cairo F, Pagliaro U, Nieri M. Treatment of gingival recession with coronally advanced flap procedures: A systematic review. J Clin Periodontol 2008;35(Suppl. 8):136-162.
24. Miller PD Jr. A classification of marginal tissue recession. Int J Periodontics Restorative Dent 1985;5(2): 8-13.
25. Silness J, Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964;22:121-135.
26. Löe H. The gingival index, the plaque index and the retention index systems. J Periodontol 1967;38:610-616.
27. Lindhe J, Lang NP, Karring T. Clinical Periodontology and Implant Dentistry, 5th ed. Oxford: Blackwell Munksgaard; 2008;541-569, 901-954.
28. Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration; 2011; v.5.0.2. Available at: www.cochrane-handbook.org. Accessed March 2011.
29. Heijl L, Heden G, Svärdström G, Ostgren A. Enamel matrix derivative (EMDOGAIN) in the treatment of intrabony periodontal defects. J Clin Periodontol 1997;24:705-714.
30. Pontoriero R, Wennström J, Lindhe J. The use of barrier membranes and enamel matrix proteins in the treatment of angular bone defects. A prospective controlled clinical study. J Clin Periodontol 1999;26: 833-840.
31. Okuda K, Momose M, Miyazaki A, et al. Enamel matrix derivative in the treatment of human intrabony osseous defects. J Periodontol 2000;71:1821-1828.
32. Silvestri M, Ricci G, Rasperini G, Sartori S, Cattaneo V. Comparison of treatments of infrabony defects with enamel matrix derivative, guided tissue regeneration with a nonresorbable membrane and Widman modified flap. A pilot study. J Clin Periodontol 2000;27: 603-610.
33. Pietruska MD. A comparative study on the use of Bio-Oss and enamel matrix derivative (Emdogain) in the treatment of periodontal bone defects. Eur J Oral Sci 2001;109:178-181.
34. Tonetti MS, Lang NP, Cortellini P, et al. Enamel matrix proteins in the regenerative therapy of deep intrabony defects. J Clin Periodontol 2002;29:317-325.
35. Zucchelli G, Bernardi F, Montebugnoli L, De SM. Enamel matrix proteins and guided tissue regeneration with titanium-reinforced expanded polytetrafluoroethy-lene membranes in the treatment of infrabony defects: A comparative controlled clinical trial. J Periodontol 2002;73:3-12.
36. Zucchelli G, Amore C, Montebugnoli L, De Sanctis M. Enamel matrix proteins and bovine porous bone mineral in the treatment of intrabony defects: A comparative controlled clinical trial. J Periodontol 2003;74:1725-1735.
37. Francetti L, Del Fabbro M, Basso M, Testori T, Weinstein R. Enamel matrix proteins in the treatment of intra-bony defects. A prospective 24-month clinical trial. J Clin Periodontol 2004;31:52-59.
38. Sanz M, Tonetti MS, Zabalegui I, et al. Treatment of intrabony defects with enamel matrix proteins or barrier membranes: Results from a multicenter practice-based clinical trial. J Periodontol 2004;75:726-733.
39. Francetti L, Trombelli L, Lombardo G, et al. Evaluation of efficacy of enamel matrix derivative in the treatment of intrabony defects: A 24-month multicenter study. Int J Periodontics Restorative Dent 2005;25:461-473.
40. Rösing CK, Aass AM, Mavropoulos A, Gjermo P. Clinical and radiographic effects of enamel matrix derivative in the treatment of intrabony periodontal defects: A 12-month longitudinal placebo-controlled clinical trial in adult periodontitis patients. J Periodon-tol 2005;76:129-133.
41. Bokan I, Bill JS, Schlagenhauf U. Primary flap closure combined with Emdogain alone or Emdogain and Cerasorb in the treatment of intra-bony defects. J Clin Periodontol 2006;33:885-893.
42. Sculean A, Schwarz F, Miliauskaite A, et al. Treatment of intrabony defects with an enamel matrix protein derivative or bioabsorbable membrane: An 8-year follow-up split-mouth study. J Periodontol 2006;77: 1879-1886.
43. Sculean A, Pietruska M, Arweiler NB, Auschill TM, Nemcovsky C. Four-year results of a prospective-controlled clinical study evaluating healing of intra-bony defects following treatment with an enamel matrix protein derivative alone or combined with a bioactive glass. J Clin Periodontol 2007;34:507-513.
44. Sculean A, Kiss A, Miliauskaite A, Schwarz F, Arweiler NB, Hannig M. Ten-year results following treatment of intra-bony defects with enamel matrix proteins and guided tissue regeneration. J Clin Periodontol 2008; 35:817-824.
45. Fickl S, Thalmair T, Kebschull M, Böhm S, Wachtel H. Microsurgical access flap in conjunction with enamel matrix derivative for the treatment of intra-bony defects: A controlled clinical trial. J Clin Periodontol 2009;36:784-790.
46. Grusovin MG, Esposito M. The efficacy of enamel matrix derivative (Emdogain) for the treatment of deep infrabony periodontal defects: A placebo-controlled randomised clinical trial. Eur J Oral Implantol-ogy 2009;2:43-54.
47. Leknes KN, Andersen KM, Bøe OE, Skavland RJ, Albandar JM. Enamel matrix derivative versus bioactive ceramic filler in the treatment of intrabony defects: 12-month results. J Periodontol 2009;80: 219-227.
48. Jepsen S, Heinz B, Jepsen K, et al. A randomized clinical trial comparing enamel matrix derivative and membrane treatment of buccal Class II furcation involvement in mandibular molars. Part I: Study design and results for primary outcomes. J Periodontol 2004; 75:1150-1160.
49. McGuire MK, Nunn M. Evaluation of human recession defects treated with coronally advanced flaps and either enamel matrix derivative or connective tissue. Part 1: Comparison of clinical parameters. J Peri-odontol 2003;74:1110-1125.
50. Del Pizzo M, Zucchelli G, Modica F, Villa R, Debernardi C. Coronally advanced flap with or without enamel matrix derivative for root coverage: A 2-year study. J Clin Periodontol 2005;32:1181-1187.
51. Spahr A, Haegewald S, Tsoulfidou F, et al. Coverage of Miller class I and II recession defects using enamel matrix proteins versus coronally advanced flap technique: A 2-year report. J Periodontol 2005;76:1871-1880.
52. Castellanos A, de la Rosa M, de la Garza M, Caffesse RG. Enamel matrix derivative and coronal flaps to cover marginal tissue recessions. J Periodontol 2006; 77:7-14.
53. Pilloni A, Paolantonio M, Camargo PM. Root coverage with a coronally positioned flap used in combination with enamel matrix derivative: 18-month clinical evaluation. J Periodontol 2006;77:2031-2039.
54. Abolfazli N, Saleh-Saber F, Eskandari A, Lafzi A. A comparative study of the long term results of root coverage with connective tissue graft or enamel matrix protein: 24-month results. Med Oral Patol Oral Cir Bucal 2009;14:E304-E309.
55. Froum SJ, Weinberg MA, Rosenberg E, Tarnow D. A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: A 12-month re-entry study. J Periodontol 2001;72:25-34.
56. Sculean A, Donos N, Miliauskaite A, Arweiler N, Brecx M. Treatment of intrabony defects with enamel matrix proteins or bioabsorbable membranes. A 4-year follow-up split-mouth study. J Periodontol 2001;72: 1695-1701.
57. Sculean A, Windisch P, Chiantella GC, Donos N, Brecx M, Reich E. Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. A prospective controlled clinical study. J Clin Periodontol 2001;28:397-403.
58. Wachtel H, Schenk G, Böhm S, Weng D, Zuhr O, Hürzeler MB. Microsurgical access flap and enamel matrix derivative for the treatment of periodontal intrabony defects: A controlled clinical study. J Clin Periodontol 2003;30:496-504.
59. Silvestri M, Sartori S, Rasperini G, Ricci G, Rota C, Cattaneo V. Comparison of infrabony defects treated with enamel matrix derivative versus guided tissue regeneration with a nonresorbable membrane. J Clin Periodontol 2003;30:386-393.
60. Parodi R, Santarelli GA, Gasparetto B. Treatment of intrabony pockets with Emdogain: Results at 36 months. Int J Periodontics Restorative Dent 2004;24: 57-63.
61. Sculean A, Donos N, Schwarz F, Becker J, Brecx M, Arweiler NB. Five-year results following treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. J Clin Periodontol 2004; 31:545-549.
62. Sculean A, Windisch P, Keglevich T, Gera I. Clinical and histologic evaluation of an enamel matrix protein derivative combined with a bioactive glass for the treatment of intrabony periodontal defects in humans. Int J Periodontics Restorative Dent 2005;25:139-147.
63. Crea A, Dassatti L, Hoffmann O, Zafiropoulos GG, Deli G. Treatment of intrabony defects using guided tissue regeneration or enamel matrix derivative: A 3-year prospective randomized clinical study. J Periodontol 2008;79:2281-2289.
64. Meyle J, Gonzales JR, Bödeker RH, et al. A randomized clinical trial comparing enamel matrix derivative and membrane treatment of buccal class II furcation involvement in mandibular molars. Part II: Secondary outcomes. J Periodontol 2004;75:1188-1195.
65. Hoffmann T, Richter S, Meyle J, et al. A randomized clinical multicentre trial comparing enamel matrix derivative and membrane treatment of buccal class II furcation involvement in mandibular molars. Part III: Patient factors and treatment outcome. J Clin Peri-odontol 2006;33:575-583.
66. Chitsazi MT, Mostofi Zadeh Farahani R, Pourabbas M, Bahaeddin N. Efficacy of open flap debridement with and without enamel matrix derivatives in the treatment of mandibular degree II furcation involvement. Clin Oral /nvestig 2007;11:385-389.
67. Casarin RC, Del Peloso Ribeiro E, Nociti FH Jr, et al. A double-blind randomized clinical evaluation of enamel matrix derivative proteins for the treatment of proximal class-II furcation involvements. J Clin Periodontol 2008;35:429-437.
68. Hägewald S, Spahr A, Rompola E, Haller B, Heijl L, Bernimoulin JP. Comparative study of Emdogain and coronally advanced flap technique in the treatment of human gingival recessions. A prospective controlled clinical study. J Clin Periodontol 2002;29:35-41.
69. Nemcovsky CE, Artzi Z, Tal H, Kozlovsky A, Moses O. A multicenter comparative study of two root coverage procedures: Coronally advanced flap with addition of enamel matrix proteins and subpedicle connective tissue graft. J Periodontol 2004;75:600-607.
70. Moses O, Artzi Z, Sculean A, et al. Comparative study of two root coverage procedures: A 24-month follow-up multicenter study. J Periodontol 2006;77:195-202.
71. Aroca S, Keglevich T, Nikolidakis D, et al. Treatment of class III multiple gingival recessions: A randomized-clinical trial. J Clin Periodontol 2010;37:88-97.
72. Ramfjord SP, Nissle RR. The modified widman flap. J Periodontol 1974;45:601-607.
73. Cortellini P, Prato GP, Tonetti MS. The modified papilla preservation technique. A new surgical approach for interproximal regenerative procedures. J Periodontol 1995;66:261-266.
74. Cortellini P, Prato GP, Tonetti MS. The simplified papilla preservation flap. A novel surgical approach for the management of soft tissues in regenerative procedures. Int J Periodontics Restorative Dent 1999;19:589-599.
75. Cortellini P, Tonetti MS. A minimally invasive surgical technique with an enamel matrix derivative in the regenerative treatment of intra-bony defects: A novel approach to limit morbidity. J Clin Periodontol 2007;34:87-93.
76. Cortellini P, Tonetti MS. Minimally invasive surgical technique and enamel matrix derivative in intra-bony defects. I: Clinical outcomes and morbidity. J Clin Periodontol 2007;34:1082-1088.
77. Cortellini P, Tonetti MS. Clinical performance of a regenerative strategy for intrabony defects: Scientific evidence and clinical experience. J Periodontol 2005;76:341-350.
78. Trejo PM, Weltman RL. Favorable periodontal regenerative outcomes from teeth with presurgical mobility: A retrospective study. J Periodontol 2004;75:1532-1538.
79. Wikesjö UM, Nilvéus RE, Selvig KA. Significance of early healing events on periodontal repair: A review. J Periodontol 1992;63:158-165.
80. Bergström J. Tobacco smoking and chronic destructive periodontal disease. Odontology 2004;92:1-8.
81. Loos BG, Louwerse PH, Van Winkelhoff AJ, et al. Use of barrier membranes and systemic antibiotics in the treatment of intraosseous defects. J Clin Periodontol 2002;29:910-921.
82. Sculean A, Blaes A, Arweiler N, Reich E, Donos N, Brecx M. The effect of postsurgical antibiotics on the healing of intrabony defects following treatment with enamel matrix proteins. J Periodontol 2001;72:190-195.
83. Sculean A, Auschill TM, Donos N, Brecx M, Arweiler NB. Effect of an enamel matrix protein derivative (Emdogain) on ex vivo dental plaque vitality. J Clin Periodontol 2001;28:1074-1078.
84. Spahr A, Lyngstadaas SP, Boeckh C, Andersson C, Podbielski A, Haller B. Effect of the enamel matrix derivative Emdogain on the growth of periodontal pathogens in vitro. J Clin Periodontol 2002;29:62-72.
85. Lundgren D, Slotte C. Reconstruction of anatomically complicated periodontal defects using a bioresorbable GTR barrier supported by bone mineral. A 6-month follow-up study of 6 cases. J Clin Periodontol 1999;26: 56-62.
86. Silva CO, Sallum AW, de Lima AF, Tatakis DN. Coronally positioned flap for root coverage: Poorer outcomes in smokers. J Periodontol 2006;77:81-87.
87. Martins AG, Andia DC, Sallum AW, Sallum EA, Casati MZ, Nociti Júnior FH. Smoking may affect root coverage outcome: A prospective clinical study in humans. J Periodontol 2004;75:586-591.
88. American Academy of Periodontology. Consensus report. Mucogingival therapy. Ann Periodontol 1996;1:702-706.